Stockreport

YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting

YS Biopharma Co., Ltd. - Ordinary Shares  (YS) 
PDF GAITHERSBURG, Md., Feb. 16, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to d [Read more]